We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT00453583
Previous Study | Return to List | Next Study

Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00453583
Recruitment Status : Completed
First Posted : March 29, 2007
Last Update Posted : December 16, 2013
Information provided by (Responsible Party):
UCB Pharma

Brief Summary:
This is a non-interventional retrospective data collection study from children aged from 2 to 12 years old diagnosed with an allergy and who received a treatment consisting of an H1-antihistamine. The period of last taken medication will be observed to evaluate the global satisfaction of the parents and physician for this last treatment.

Condition or disease

Layout table for study information
Study Type : Observational
Actual Enrollment : 4581 participants
Time Perspective: Retrospective
Official Title: Evaluation of the Treatment Satisfaction in Children Suffering From an Allergy and Who Received an Antihistamine Treatment
Study Start Date : March 2007
Actual Primary Completion Date : January 2008
Actual Study Completion Date : January 2008

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. Parent satisfaction on a 11-point scale [ Time Frame: duration of the study ]

Secondary Outcome Measures :
  1. Physician satisfaction on an 11-point scale [ Time Frame: duration of the study ]
  2. Efficacy, tolerability and global satisfaction [ Time Frame: duration of the study ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   2 Years to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Primary Care

Inclusion Criteria:

  • Children from 2-12 included
  • History of allergy
  • Used an Antihistamine within market authorization

Exclusion Criteria:

  • Child not yet treated for the presented allergy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00453583

Layout table for location information
United States, Georgia
UCB Pharma
Smyrna, Georgia, United States
Sponsors and Collaborators
UCB Pharma
Layout table for investigator information
Study Director: UCB Clinical Trial Call Center +1 877 822 9493 (UCB)
Layout table for additonal information
Responsible Party: UCB Pharma
ClinicalTrials.gov Identifier: NCT00453583    
Other Study ID Numbers: A00420
First Posted: March 29, 2007    Key Record Dates
Last Update Posted: December 16, 2013
Last Verified: May 2012
Keywords provided by UCB Pharma:
Additional relevant MeSH terms:
Layout table for MeSH terms
Immune System Diseases